Pharma Market Access Pricing and Reimbursement Conference

From the event organizers:

The conference will provide attendees with an opportunity to learn about the key developments impacting the future of pharmaceutical pricing and reimbursement, including:

  • The increasing importance of generating, collecting and analyzing reimbursement evidence early in product development and identifying points of differentiation of a product versus existing standards of care
  • The impact of Health Technology Assessments (HTAs) on both private and public payer reimbursement decisions
  • Coverage with Evidence Development (CED) and performance-based risk-sharing agreements, based on long-term outcomes
  • The role of comparative effectiveness in future clinical trials and reimbursement decisions
    Value-based pricing, which requires companies to back up reimbursement claims with strong evidence that products are a good use of money available
  • Alternative and shared risk pricing schemes

Information here.